MetLife to Report Q3 Earnings: What Do the Key Estimates Say?

03.11.25 18:31 Uhr

Werte in diesem Artikel
Aktien

68,39 EUR 1,50 EUR 2,24%

Indizes

PKT PKT

17.784,7 PKT -21,1 PKT -0,12%

3.412,0 PKT -4,0 PKT -0,12%

6.771,5 PKT -0,1 PKT 0,00%

Leading global insurer MetLife, Inc. MET is set to report third-quarter 2025 results on Nov. 5, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $2.33 per share on revenues of $18.8 billion.The third-quarter earnings estimate has improved over the past 30 days. The bottom-line projection indicates a year-over-year growth of 20.7%. The Zacks Consensus Estimate for quarterly revenues suggests a year-over-year growth of 7%.Image Source: Zacks Investment ResearchFor the current year, the Zacks Consensus Estimate for MetLife’s revenues is pegged at $74.6 billion, implying a rise of 2.1% year over year. Also, the consensus mark for current-year EPS is pegged at $8.69, calling for a jump of around 7.2% on a year-over-year basis.MET missed the consensus estimate for earnings in each of the last four quarters.MetLife, Inc. Price and EPS Surprise MetLife, Inc. price-eps-surprise | MetLife, Inc. QuoteQ3 Earnings Whispers for METOur proven model does not conclusively predict an earnings beat for MetLife this time as well. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here.MET has an Earnings ESP of -0.23% and carries a Zacks Rank #3 at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.What’s Shaping MET’s Q3 Results?MetLife’s third-quarter revenue growth is expected to have been driven by rising premiums and adjusted group benefits revenues. Improving operations in the international markets, especially in Asia, EMEA and Latin America, is a major positive. The Zacks Consensus Estimate for premiums for the to-be-reported quarter suggests an increase of 7.2% from the prior-year quarter.The Zacks Consensus Estimate for total adjusted group benefits revenue for the to-be-reported quarter suggests an increase of 2.8% from the prior-year quarter. Improving profits from Asia and Latin American operations are expected to have positioned the company for significant growth from the year-ago period. Improved net investment income is likely to have aided the Asia segment, while EMEA and the Latin America businesses are expected to have gained from higher volumes.Adjusted earnings from the Latin America business are likely to have witnessed 10.6% year-over-year growth in the third quarter.The factors mentioned above are expected to have contributed to MetLife's year-over-year growth. However, rising costs and expenses are likely to have partially offset the profit growth levels in the to-be-reported quarter. Also, the Zacks Consensus Estimate for adjusted earnings from the Retirement and Income Solutions for the to-be-reported quarter suggests a decline of 13% from the prior-year quarter.Stocks That Warrant a LookHere are some companies worth considering from the broader Finance space, as our model shows that these have the right combination of elements to beat on earnings this time:HCI Group, Inc. HCI currently has an Earnings ESP of +87.40% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for HCI Group’s bottom line for the to-be-reported quarter is pegged at $2.35 per share, indicating 400% year-over-year growth. It has remained stable over the past seven days. The consensus estimate for HCI Group’s revenues is pegged at $224.9 billion.Essent Group Ltd. ESNT has an Earnings ESP of +4.20% and carries a Zacks Rank #3 at present.The Zacks Consensus Estimate for Essent Group’s bottom line for the to-be-reported quarter is pegged at $1.75 per share, indicating 6.1% year-over-year growth. It has remained stable over the past seven days. The consensus estimate for Essent Group’s revenues is pegged at $308.2 million.Assurant, Inc. AIZ presently has an Earnings ESP of +4.14% and a Zacks Rank of 3.The Zacks Consensus Estimate for Assurant’s earnings for the to-be-reported quarter is pegged at $4.23 per share, indicating 41% year-over-year growth. The consensus estimate for revenues is pegged at $3.2 billion. Assurant beat earnings estimates in each of the past four quarters, with the average surprise being 18.9%.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis Report Assurant, Inc. (AIZ): Free Stock Analysis Report HCI Group, Inc. (HCI): Free Stock Analysis Report Essent Group Ltd. (ESNT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen